Lupkynis 7.9 MG Oral Capsule
- RxCUI
- 2475406
- RxNorm name
- Lupkynis 7.9 MG Oral Capsule
- Display name
- Lupkynis 7.9 MG Oral Capsule
- Full name
- Lupkynis 7.9 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LUPKYNIS | VOCLOSPORIN | Aurinia Pharma U.S., Inc. | 9f489295-1156-52c7-5fd0-5c4c52f9b813 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 2475406 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9f489295-1156-52c7-5fd0-5c4c52f9b813 | Lupkynis 7.9 MG Oral Capsule [PSN] · voclosporin 7.9 MG Oral Capsule [Lupkynis] [SBD] · Lupkynis 7.9 MG Oral Capsule [SY] | 3 | 11 | These highlights do not include all the information needed to use LUPKYNIS ® safely and effectively. See full prescribing information for LUPKYNIS. LUPKYNIS (voclosporin) capsules, for oral use Initial U.S. Approval: 2021 | 20251008 |